# language_name_wals:	English
# language_name_glotto:	English
# ISO_6393:	eng
# year_composed:	NA
# year_published:	NA
# mode:	written
# genre_broad:	technical
# genre_narrow:	NA
# writing_system:	Latn
# special_characters:	NA
# short_description:	EMEA
# source:	https://object.pouta.csc.fi/OPUS-EMEA/v3/raw/en.zip
# copyright_short:	http://opus.nlpl.eu/EMEA.php
# copyright_long:	http://opus.nlpl.eu/EMEA.php J. Tiedemann, 2012, Parallel Data, Tools and Interfaces in OPUS. In Proceedings of the 8th International Conference on Language Resources and Evaluation (LREC 2012)
# sample_type:	whole
# comments:	NA

ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
1 1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Netvax emulsion for injection for chickens
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose (0.5ml) contains:
Active substance:
Clostridium perfringens Type A alpha toxoid
Not less than 6.8 IU *
Adjuvant
Light Mineral Oil
0.31 ml
Excipients
Thiomersal
0.035-0.05 mg
* International units per ml of rabbit serum determined by haemolysis inhibition assay
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Emulsion for injection Off white oily emulsion.
4.
CLINICAL PARTICULARS
4.1 Target species
Chickens
4.2 Indications for use, specifying the target species
For the active immunization of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.
To reduce mortality and the incidence and severity of lesions caused by Clostridium perfringens Type A induced necrotic enteritis.
Efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.
The onset of passive transfer of immunity:
6 weeks following completion of the vaccination procedure
The duration of passive transfer of immunity:
51 weeks following completion of the vaccination procedure
4.3 Contraindications
None
2 4.4 Special warnings
None.
4.5 Special precautions for use
None
Special precautions for use in animals None
Special precautions to be taken by the person administering the veterinary medicinal product to animals
To the user:
This product contains mineral oil.
Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you.
If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This product contains mineral oil.
Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit.
Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
4.6 Adverse reactions (frequency and seriousness)
No systemic reactions to vaccination were seen following intramuscular vaccination.
Vaccination may result in moderate swelling of the breast tissue which will resolve within 30 days.
Following the second vaccination swelling may persist for at least 35 days.
Swelling was very common.
4.7 Use during pregnancy, lactation or lay
The vaccine is safe for use in laying and breeding birds.
4.8 Interaction with other medicinal products and other forms of interaction
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product.
A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis
4.9 Amounts to be administered and administration route
Vaccinate chickens by the intramuscular route into the breast.
One dose of 0.5 ml should be given at 10 to 14 weeks of age.
A second dose of 0.5 ml should be administered 4 to 10 weeks after the first vaccination.
The second dose should be administered no later than 6 weeks before the onset of lay.
Shake well before use.
Syringes and needles must be sterile before use.
Follow usual aseptic procedures.
3 4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
After administration of a double dose, local reactions may increase slightly.
(see section 4.6)..
4.11 Withdrawal period(s)
Zero days
5.
IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group:
Immunologicals for aves, ATC vet code:
QI01AB08
To stimulate active immunity in chickens, in order to provide passive protection to the progeny against Clostridium perfringens Type A induced necrotic enteritis.
6.
PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Light Mineral Oil Thiomersal Formaldehyde Sorbitan oleate Polysorbate 80 Benzyl Alcohol Triethanolamine EDTA Sodium Chloride
6.2 Incompatibilities
Do not mix with any other veterinary medicinal product.
6.3 Shelf life
Shelf-life of the veterinary medicinal product as packaged for sale:
18 months.
Shelf-life after first opening the immediate packaging:
Use Immediately
6.4.
Special precautions for storage
Store and transport refrigerated (2ºC - 8°C).
Do not freeze.
Protect from light.
6.5 Nature and composition of immediate packaging
500ml high density polyethylene (HDPE) flexible bottle closed with a chlorobutyl rubber closure held in place with an aluminium seal with centre hole.
Pack Sizes 1 x 500ml 6 x 500ml Not all pack sizes may be marketed
4 6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7.
MARKETING AUTHORISATION HOLDER
Intervet International B. V.
Wim de Körverstraat 35 5831AN Boxmeer The Netherlands
8.
MARKETING AUTHORISATION NUMBER(S)
EU/ 2/ 09/ 093/ 001 EU/ 2/ 09/ 093/ 002
9.
DATE OF FIRST AUTHORISATION/ RENEWAL OF THE AUTHORISATION
16/ 04/ 2009
10.
DATE OF REVISION OF THE TEXT
16/ 04/ 2009
PROHIBITION OF SALE, SUPPLY AND/ OR USE
Not applicable.
5 ANNEX II
A.
MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE
B.
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE
C.
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO SAFE AND EFFECTIVE USE
D.
STATEMENT OF THE MRLs
6 A.
MANUFACTURER(S) OF THE BIOLOGICAL ACTIVE SUBSTANCE(S) AND MANUFACTURING AUTHORISATION HOLDER(S) RESPONSIBLE FOR BATCH RELEASE
Name and address of the manufacturer of the biological active substance(s)
Schering-Plough Animal Health 33 Whakatiki Street Upper Hutt New Zealand
Name and address of the manufacturer responsible for batch release
S-P Veterinary Ltd Breakspear Road South Harefield Uxbridge UB9 6LS United Kingdom
B.
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY OR USE
Veterinary medicinal product subject to prescription.
C.
CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE PRODUCT
According to Article 71 of Directive 2001/ 82/ EC as amended, Member States prohibit or may prohibit the import, sale, supply and/ or use of the veterinary medicinal product on the whole or part of their territory if it is established that:
a) the administration of the veterinary medicinal product to animals will interfere with the implementation of a national programme for the diagnosis, control and eradication of animal disease, or will cause difficulties in certifying the absence of contamination in live animals or in foodstuffs or other products obtained from treated animals b) the disease to which the veterinary medicinal product is intended to confer immunity is largely absent from the territory.
7 D.
STATEMENT OF THE MRLs
Pharmacologically
Animal species
Other
active substance(s)
provisions
Thiomersal
All food producing species
Annex II of Council Regulation (EEC) No.
2377/ 90
EDTA
All food producing species
Annex II of Council Regulation (EEC) No.
2377/ 90
Formaldehyde
All food producing species
Annex II of Council Regulation (EEC) No.
2377/ 90
Mineral oil
All food producing species
Annex II of Council Regulation (EEC) No.
2377/ 90
Benzyl alcohol
All food producing species
Annex II of Council Regulation (EEC) No.
2377/ 90
Triethanolamine (at doses up to 0.25 mg/ kg bw) is considered not within the scope of Council Regulation (EEC) No.
2377/ 90.
8 ANNEX III
LABELLING AND PACKAGE LEAFLET
9 A.
LABELLING
10 PARTICULARS TO APPEAR ON THE OUTER PACKAGE
Carton
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Netvax Emulsion for injection for chickens
2.
STATEMENT OF ACTIVE AND OTHER SUBSTANCES
Per dose of 0.5ml:
Clostridium perfringens Type A alpha toxoid: ≥ 6.8 IU* Light mineral oil:
0.31 ml Thiomersal:
0.035-0.05 mg
* International units per ml of rabbit serum determined by haemolysis inhibition assay
3.
PHARMACEUTICAL FORM
4.
PACKAGE SIZE
1 x 500ml 6 x 500ml
5.
TARGET SPECIES
Chickens
6.
INDICATION(S)
Vaccine against necrotic enteritis
7.
METHOD AND ROUTE(S) OF ADMINISTRATION
Intramuscular use.
Shake well before use.
Read the package leaflet before use
8.
WITHDRAWAL PERIOD
Withdrawal period:
Zero days
11 9.
SPECIAL WARNING(S), IF NECESSARY
Accidental injection is dangerous – read package leaflet before use.
10.
EXPIRY DATE
EXP month/ year Once opened, use immediately
11.
SPECIAL STORAGE CONDITIONS
Store and transport refrigerated (2ºC- 8ºC).
Do not freeze Protect from light
12.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY
Disposal: read package leaflet
13.
THE WORDS “ FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable
For animal treatment only.
To be supplied only on veterinary prescription.
14.
THE WORDS “ KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”
Keep out of the reach and sight of children.
15.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Intervet International B. V.
Wim de Körverstraat 35 5831AN Boxmeer The Netherlands
16.
MARKETING AUTHORISATION NUMBER(S)
EU/ 2/ 09/ 093/ 001 EU/ 2/ 09/ 093/ 002
12 17.
MANUFACTURER’ S BATCH NUMBER
Batch {number}
13 MINIMUM PARTICULARS TO APPEAR ON IMMEDIATE PACKAGING UNITS
Label
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Netvax Emulsion for injection for chickens
2.
STATEMENT OF ACTIVE AND OTHER SUBSTANCES
Per dose of 0.5ml:
Clostridium perfringens Type A alpha toxoid: ≥ 6.8 IU* Light mineral oil:
0.31 ml Thiomersal:
0.035-0.05 mg
* International units per ml of rabbit serum determined by haemolysis inhibition assay
3.
PHARMACEUTICAL FORM
4.
PACKAGE SIZE
1 x 500ml 6 x 500ml
5.
TARGET SPECIES
Chickens
6.
INDICATION(S)
Vaccine against necrotic enteritis
7.
METHOD AND ROUTE(S) OF ADMINISTRATION
Intramuscular use.
Shake well before use.
Read the package leaflet before use
8.
WITHDRAWAL PERIOD
Withdrawal period:
Zero days
14 9.
SPECIAL WARNING(S), IF NECESSARY
Accidental injection is dangerous – read package leaflet before use.
10.
EXPIRY DATE
EXP month/ year Once opened, use immediately
11.
SPECIAL STORAGE CONDITIONS
Store and transport refrigerated (2ºC- 8ºC).
Do not freeze Protect from light
12.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR WASTE MATERIALS, IF ANY
13.
THE WORDS “ FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE, if applicable
For animal treatment only.
To be supplied only on veterinary prescription.
14.
THE WORDS “ KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”
Keep out of the reach and sight of children.
15.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Intervet International B. V.
Wim de Körverstraat 35 5831AN Boxmeer The Netherlands
16.
MARKETING AUTHORISATION NUMBER(S)
EU/ 2/ 09/ 093/ 001 EU/ 2/ 09/ 093/ 002
15 17.
MANUFACTURER’ S BATCH NUMBER
Batch {number}
16 B.
PACKAGE LEAFLET
17 PACKAGE LEAFLET FOR
Netvax emulsion for injection for chickens
1.
NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT
Marketing authorisation holder:
Intervet International B. V.
Wim de Körverstraat 35 5831AN Boxmeer The Netherlands
Manufacturer for the batch release:
S-P Veterinary Ltd Breakspear Road South Harefield Uxbridge Middlesex, UB9 6LS United Kingdom
2.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Netvax emulsion for injection for chickens
3.
STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S)
One dose (0.5ml) contains:
Active substance:
Clostridium perfringens Type A alpha toxoid Adjuvant
Not less than 6.8 IU *
Light Mineral Oil Excipients
0.31 ml
Thiomersal
0.035-0.05 mg
* International units per ml of rabbit serum determined by haemolysis inhibition assay
4.
INDICATION(S)
For the active immunization of chickens to provide passive immunisation against necrotic enteritis to their progeny, during the laying period.
To reduce mortality and the incidence and severity of lesions caused by Clostridium perfringens Type A induced necrotic enteritis.
Efficacy was demonstrated by challenge of chicks approximately three weeks after hatching.
18 The onset of passive transfer of immunity:
6 weeks following completion of the vaccination procedure
The duration of passive transfer of immunity:
51 weeks following completion of the vaccination procedure
5.
CONTRAINDICATIONS
None
6.
ADVERSE REACTIONS
No systemic reactions to vaccination were seen following intramuscular vaccination.
Vaccination may result in moderate swelling of the breast tissue which will resolve within 30 days.
Following the second vaccination swelling may persist for at least 35 days.
Swelling was very common.
After administration of a double dose, local reactions may increase slightly.
If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon.
7.
TARGET SPECIES
Chickens
8.
DOSAGE FOR EACH SPECIES, ROUTE(S) AND METHOD OF ADMINISTRATION
Vaccinate chickens by the intramuscular route into the breast.
One dose of 0.5 ml should be given at 10 to 14 weeks of age.
A second dose of 0.5 ml should be administered 4 to 10 weeks after the first vaccination.
The second dose should be administered no later than 6 weeks before the onset of lay.
9.
ADVICE ON CORRECT ADMINISTRATION
Shake well before use.
Syringes and needles must be sterile before use.
Follow usual aseptic procedures.
10.
WITHDRAWAL PERIOD
None
11.
SPECIAL STORAGE PRECAUTIONS
Keep out of the reach and sight of children.
Store and transport refrigerated (2ºC- 8ºC).
Do not freeze.
Protect from light.
Do not use after the expiry date stated on the carton.
Shelf-life after first opening the immediate packaging: - Use immediately
19 12.
SPECIAL WARNING(S)
Special precautions to be taken by the person administering the veterinary medicinal product to animals
To the user:
This product contains mineral oil.
Accidental injection/ self injection may result in severe pain and swelling, particularly if injected into a joint or finger, and in rare cases could result in the loss of the affected finger if prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt medical advice even if only a very small amount is injected and take the package leaflet with you.
If pain persists for more than 12 hours after medical examination, seek medical advice again.
To the physician:
This product contains mineral oil.
Even if small amounts have been injected, accidental injection with this product can cause intense swelling, which may, for example, result in ischaemic necrosis and even the loss of a digit.
Expert, PROMPT, surgical attention is required and may necessitate early incision and irrigation of the injected area, especially where there is involvement of finger pulp or tendon.
No information is available on the safety and efficacy of this vaccine when used with any other veterinary medicinal product.
A decision to use this vaccine before or after any other veterinary medicinal product therefore needs to be made on a case by case basis.
13.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCT OR WASTE MATERIALS, IF ANY
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with national requirements.
14.
DATE ON WHICH THE PACKAGE LEAFLET WAS LAST APPROVED
16/ 04/ 2009
15.
OTHER INFORMATION
To stimulate active immunity in chickens, in order to provide passive protection to the progeny against Clostridium perfringens Type A induced necrotic enteritis.
Pack sizes:
1 x 500ml 6 x 500ml Not all pack sizes may be marketed
For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
20